HealthEquity Reports Fourth Quarter and Year Ended January 31, 2017 Financial Results

Go back to HealthEquity Reports Fourth Quarter and Year Ended January 31, 2017 Financial Results

HealthEquity, Inc (HQY) PT Raised to $51 at JPMorgan

March 22, 2017 8:25 AM EDT

JPMorgan raised its price target on HealthEquity, Inc (NASDAQ: HQY) to $51.00 (from $44.00) while maintaining a Overweight rating.

... More

HealthEquity (HQY) Tops Q4 EPS by 3c

March 21, 2017 4:08 PM EDT

HealthEquity (NASDAQ: HQY) reported Q4 EPS of $0.07, $0.03 better than the analyst estimate of $0.04. Revenue for the quarter came in at $46.8 million versus the consensus estimate of $45.59 million.

Revenue of $46.8 million, an increase of 30% compared to Q4 FY16.Net income of... More